World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
27310
World Ranking
10603
National Ranking
5453

Biology and Biochemistry

D-Index
94
Citations
27111
World Ranking
2044
National Ranking
1113

Michael R. Freeman publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Michael R. Freeman sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 429 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Michael R. Freeman D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Michael R. Freeman sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 94 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Michael R. Freeman is affiliated with Cedars-Sinai Medical Center in the United States. Their research spans several fields primarily within biochemistry, genetics, molecular biology, and medicine.

The main fields of study in their scientific work include:

  • Biochemistry, Genetics and Molecular Biology
  • Medicine

Within these, subfields of focus include:

  • Molecular Biology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Oncology
  • Immunology

Their published work emphasizes topics such as:

  • Prostate Cancer Treatment and Research
  • Cancer, Lipids, and Metabolism
  • PARP inhibition in cancer therapy
  • Ubiquitin and proteasome pathways
  • Cancer-related gene regulation
  • Cancer, Hypoxia, and Metabolism
  • RNA modifications and cancer

Michael R. Freeman has contributed to numerous research articles, including the following recent papers:

  • Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer, 2020, Clinical Cancer Research
  • A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma, 2021, Cancer Research
  • Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles, 2020, Journal of Extracellular Vesicles
  • Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis, 2022, Nature Communications
  • NTIRE 2022 Challenge on Night Photography Rendering, 2022, 2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW)

Frequent co-authors in their scientific collaborations include:

  • Sungyong You
  • Edwin M. Posadas
  • Stephen J. Freedland
  • Minhyung Kim
  • Wei Yang

The venues where Michael R. Freeman most often publishes are:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • arXiv (Cornell University)

Best Publications

  • Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.

    Valentina R. Minciacchi;Michael R. Freeman;Dolores Di Vizio;Dolores Di Vizio;Dolores Di Vizio

  • Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

    Liyan Zhuang;Jayoung Kim;Rosalyn M. Adam;Keith R. Solomon

  • F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

    Rob S.B. Beanlands;Graham Nichol;Ella Huszti;Dennis Humen

  • Single photon-emission computed tomography

    Thomas A. Holly;Brian G. Abbott;Mouaz Al-Mallah;Dennis A. Calnon

  • Peripheral Blood T Lymphocytes and Lymphocytes Infiltrating Human Cancers Express Vascular Endothelial Growth Factor: A Potential Role for T Cells in Angiogenesis

    Michael R. Freeman;Francis X. Schneck;Michael L. Gagnon;Christopher Corless

  • Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

    J. L. Camps;Shi-Ming Chang;T. C. Hsu;M. R. Freeman

  • Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease.

    Dolores Di Vizio;Jayoung Kim;Martin H. Hager;Matteo Morello

  • T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells.

    Srully Blotnick;George E. Peoples;Michael R. Freeman;Timothy J. Eberlein

  • Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease

    Dolores Di Vizio;Dolores Di Vizio;Dolores Di Vizio;Matteo Morello;Matteo Morello;Matteo Morello;Andrew C. Dudley;Peter W. Schow

  • Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro.

    Anthony Atala;Joseph P. Vacanti;Craig A. Peters;James Mandell

  • Cholesterol-rich Lipid Rafts Mediate Akt-regulated Survival in Prostate Cancer Cells

    Liyan Zhuang;Jianqing Lin;Michael L Lu;Keith R Solomon

  • Large oncosomes contain distinct protein cargo and represent a separate functional class of tumor-derived extracellular vesicles

    Valentina R. Minciacchi;Sungyong You;Cristiana Spinelli;Samantha Morley;Samantha Morley

  • Cholesterol and prostate cancer.

    Kristine Pelton;Michael R Freeman;Keith R Solomon;Keith R Solomon

  • VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial.

    Duncan J Stewart;Michael Jb Kutryk;David Fitchett;Michael Freeman

  • Increased Incidence of Matrix Metalloproteinases in Urine of Cancer Patients

    Marsha A. Moses;Dmitri Wiederschain;Kevin R. Loughlin;David Zurakowski

  • Cholesterol and prostate cancer.

    Michael R. Freeman;Keith R. Solomon

  • Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma.

    Tatyana Vagner;Cristiana Spinelli;Valentina R. Minciacchi;Leonora Balaj

  • Implantation in Vivo and Retrieval of Artificial Structures Consisting of Rabbit and Human Urothelium and Human Bladder Muscle

    Anthony Atala;Michael R. Freeman;Joseph P. Vacanti;Jennifer Shepard

  • The Phosphatidylinositol 3′-kinase Pathway Is a Dominant Growth Factor-activated Cell Survival Pathway in LNCaP Human Prostate Carcinoma Cells

    Jianqing Lin;Rosalyn M. Adam;Eric Santiestevan;Michael R. Freeman

  • ASNC IMAGING GUIDELINES FOR NUCLEAR CARDIOLOGY PROCEDURES Single photon-emission computed tomography

    Thomas A. Holly;Brian G. Abbott;Mouaz Al-Mallah;Dennis A. Calnon

Frequent Co-Authors

Duncan J. Stewart
Duncan J. Stewart Ottawa Hospital Research Institute
Leland W.K. Chung
Leland W.K. Chung Cedars-Sinai Medical Center
Stephen J. Freedland
Stephen J. Freedland Cedars-Sinai Medical Center
Paul W. Armstrong
Paul W. Armstrong University of Alberta
Beatrice S. Knudsen
Beatrice S. Knudsen University of Utah
Craig A. Peters
Craig A. Peters The University of Texas Southwestern Medical Center
Hsian-Rong Tseng
Hsian-Rong Tseng University of California, Los Angeles
Daniel S. Berman
Daniel S. Berman Cedars-Sinai Medical Center
Neil A. Bhowmick
Neil A. Bhowmick Cedars-Sinai Medical Center
Hanno Steen
Hanno Steen Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are passionate about Biology and Biochemistry, several online degree options offer unique career opportunities in the health and scientific fields. For those interested in the connection between diet and health, pursuing an online nutritionist degree can open doors to roles in healthcare, fitness, and wellness education.

If you aim to move into healthcare administration, consider enrolling in online mha programs cahme accredited. These programs are ideal for those seeking leadership and management roles within hospitals or healthcare organizations.

Nursing professionals can explore advanced clinical roles through programs like online dnp programs without clinicals, which focus on leadership and policy instead of bedside practice. For those driven to reach the executive level, a doctorate in healthcare management builds expertise for strategic roles in academia, research, and healthcare administration.

Whether your interest lies in direct patient care, research, or health leadership, these tailored online pathways support long-term growth and specialized careers in the life sciences.

Best Scientists Citing Michael R. Freeman

Trending Scientists

Recently Published Articles